Athyrium Capital Management, LP - AMRYT PHARMA PLC ownership

AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 62 filers reported holding AMRYT PHARMA PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
Athyrium Capital Management, LP ownership history of AMRYT PHARMA PLC
ValueSharesWeighting
Q1 2023$129,138,967
+99.7%
8,857,2680.0%46.27%
+70.3%
Q4 2022$64,658,056
+5.5%
8,857,2680.0%27.18%
+18.4%
Q3 2022$61,292,000
-1.0%
8,857,2680.0%22.96%
-11.8%
Q2 2022$61,912,000
-15.5%
8,857,2680.0%26.04%0.0%
Q1 2022$73,250,000
-23.4%
8,857,2680.0%26.04%
-23.6%
Q4 2021$95,658,000
+75.7%
8,857,268
+96.0%
34.10%
-1.2%
Q3 2021$54,443,000
-0.7%
4,520,0000.0%34.53%
+51.1%
Q2 2021$54,828,000
-12.9%
4,520,0000.0%22.86%
-28.2%
Q1 2021$62,964,000
-1.6%
4,520,0000.0%31.84%
+3.2%
Q4 2020$64,003,0004,520,00030.84%
Other shareholders
AMRYT PHARMA PLC shareholders Q4 2021
NameSharesValueWeighting ↓
Global Frontier Investments LLC 0$00.00%
View complete list of AMRYT PHARMA PLC shareholders